Hultenby K, Reinholt F P, Oldberg A, Heinegård D
Clinical Research Centre, Karolinska Institutet, Huddinge University Hospital, Sweden.
Matrix. 1991 Jun;11(3):206-13. doi: 10.1016/s0934-8832(11)80160-5.
The ultrastructural localization of osteopontin in bone was determined especially focussing on the relationship to bone forming cells, i.e. osteoblasts and osteocytes. Thus, rat metaphyseal and cortical bone was fixed in a mixture of low concentration glutar- and paraformaldehyde and embedded at low temperature in Lowicryl K11M. Polyclonal antibodies raised against rat osteopontin fusion protein were incubated on ultrathin sections and protein G coated with 5-nm colloidal gold was used for detection. The results demonstrate most intensive labeling in the mineralization front of newly formed bone; whereas lower concentration of label was found in the osteoid both in metaphyseal and cortical bone. The concentration of marker was substantially higher in newly formed bone near osteoblasts compared to bone constituting the osteocyte lacuna. Intracellularly the prevailing localization of label was to large Golgi vesicles in osteoblasts. Only focally local accumulation of marker was seen at the cell/osteoid surface. The observations suggest a function of osteopontin also in the mineral turnover of newly formed bone.
骨桥蛋白在骨中的超微结构定位已被确定,尤其关注其与骨形成细胞(即成骨细胞和骨细胞)的关系。因此,将大鼠干骺端和皮质骨固定于低浓度戊二醛和多聚甲醛的混合液中,并在低温下包埋于Lowicryl K11M中。将针对大鼠骨桥蛋白融合蛋白产生的多克隆抗体孵育于超薄切片上,并使用包被有5纳米胶体金的蛋白G进行检测。结果显示,在新形成骨的矿化前沿标记最为强烈;而在干骺端和皮质骨的类骨质中标记浓度较低。与构成骨细胞陷窝的骨相比,靠近成骨细胞的新形成骨中标记物的浓度明显更高。在细胞内,标记物主要定位于成骨细胞的大型高尔基体囊泡中。仅在细胞/类骨质表面观察到标记物的局灶性局部积累。这些观察结果表明骨桥蛋白在新形成骨的矿物质周转中也具有一定作用。